Osiris Evaluates the Establishment Of An International Subsidiary By: Benzinga via Benzinga May 21, 2015 at 16:32 PM EDT Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading cellular and regenerative medicine company focused on developing and marketing ... Read More >> Related Stocks: Osiris Therapeutics